Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Revlimid
gptkb:Pomalyst |
| gptkbp:activities |
anti-inflammatory
|
| gptkbp:approves |
gptkb:1958
|
| gptkbp:brand |
Decadron
Dex Pak Dexamethasone Intensol |
| gptkbp:contraindication |
gptkb:Company
peptic ulcer disease systemic fungal infections severe hypertension live vaccines hypersensitivity to dexamethasone |
| gptkbp:discovered_by |
gptkb:Merck_&_Co.
|
| gptkbp:excretion |
kidneys
|
| https://www.w3.org/2000/01/rdf-schema#label |
dexamethasone
|
| gptkbp:ingredients |
C22 H29 F O5
|
| gptkbp:is_atype_of |
H02 A B02
|
| gptkbp:is_available_on |
gptkb:sneaker
gptkb:software_framework gptkb:tablet injection |
| gptkbp:is_part_of |
glucocorticoids
steroid hormones |
| gptkbp:is_used_for |
adrenal insufficiency
allergic reactions autoimmune diseases inflammation certain cancers |
| gptkbp:is_used_in |
gptkb:healthcare_organization
gptkb:psychologist gptkb:rheumatoid_arthritis gptkb:drug skin conditions gastrointestinal disorders organ transplants eye conditions severe asthma attacks cerebral edema nausea and vomiting from chemotherapy |
| gptkbp:manager |
oral
intravenous intramuscular |
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
insomnia
weight gain increased appetite mood changes high blood sugar |
| gptkbp:type_of |
1177-87-3
|